Patient Portal

Mauricio Lisker-Melman, MD

Professor, Medicine
Division of Gastroenterology
Director, Hepatology Program

Specialty Areas

Hepatology
Gastroenterology
Hepatology/Liver Disease
Endoscopy
Amyloidosis

Board Certifications

Gastroenterology
Internal Medicine
Endoscopy
Internal Medicine

Hospital Affiliations

Barnes-Jewish Hospital

Languages

Spanish
Hebrew

Areas of Clinical Interest

Acute and chronic viral hepatitis, autoimmune liver disease (AIH, PBC, PSC), liver cancer, liver transplantation

  • Maps & Directions
  • Education
  • Publication & Research
  • Financial Disclosures

Maps & Directions

Maps & Directions

Center for Advanced Medicine
Gastrointestinal Center

4921 Parkview Place
St. Louis, MO 63110

Suite: C
Floor: 8
Office Phone: 314-747-3969
Fax: 314-454-8007

Barnes-Jewish West County Hospital
Medical Building Two

10 Barnes West Drive
Creve Coeur, MO 63141

Suite: Suite 200
Office Phone: 314-747-2066
Fax: 314-747-1277

Education

Education

Medical Staff Fellow: National Institutes of Health, Bethesda, Maryland 1989
Visiting Associate: National Institutes of Health, Bethesda, Maryland 1987
Fellowship: Gastroenterology-Endoscopy, Instituto Nacional de la Nutricion Salvador Zubiran, Mexico City, Mexico 1985
Residency: Internal Medicine, Instituto Nacional de la Nutricion Salvador Zubiran, Mexico City, Mexico 1983
Medical Degree: School of Medicine, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico 1980

Publication & Research

Publication & Research

Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.
Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN)., Harvard Consortium.
Diabetes Care. 2018 Jun; 41(6)1251-1259. doi: 10.2337/dc18-0040.

PMID:
    29599296
    [PubMed - in process]
Related citations


An effectiveness study of group psychoeducation for hepatitis C patients in community clinics.
North CS, Pollio DE, Sims OT, Jain MK, Brown GR, Downs DL, Lisker-Melman M, Hong BA
Eur J Gastroenterol Hepatol. 2017 Jun; 29(6)679-685. doi: 10.1097/MEG.0000000000000860.

PMID:
    28195874
    [PubMed - indexed for MEDLINE]
Related citations


Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).
Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH
Dig Dis Sci. 2016 Apr; 61(4)1186-96. doi: 10.1007/s10620-015-4006-0.

PMID:
    26831489
    [PubMed - indexed for MEDLINE]
Related citations


Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM, Hepatitis B Research Network.
Gastroenterology. 2016 Mar; 150(3)684-695.e5. doi: 10.1053/j.gastro.2015.11.050.

PMID:
    26684441
    [PubMed - indexed for MEDLINE]
Related citations


Treatment of Hepatic Adenomatosis.
Meyer C, Lisker-Melman M
Curr Hepatol Rep. 2015 Jun; 14(2)139-143.

PMID:
    26430609
    [PubMed]
Related citations


Diabetes and prediabetes in patients with hepatitis B residing in North America.
Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, HBRN.
Hepatology. 2015 Nov; 62(5)1364-74. doi: 10.1002/hep.28110.

PMID:
    26390278
    [PubMed - indexed for MEDLINE]
Related citations


An empirical study of alcohol consumption by patients considering HCV treatment.
North CS, Sims O, Hong BA, Jain MK, Brown G, Lisker-Melman M, Pollio DE
Am J Drug Alcohol Abuse. 2014 Nov; 40(6)484-9. doi: 10.3109/00952990.2014.945592.

PMID:
    25140981
    [PubMed - indexed for MEDLINE]
Related citations


Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.
Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS, Hepatitis B Research Network., Hepatitis B Research Network.
Clin Gastroenterol Hepatol. 2015 Jan; 13(1)183-92. doi: 10.1016/j.cgh.2014.06.028.

PMID:
    25010003
    [PubMed - indexed for MEDLINE]
Related citations


Liver volume in the cirrhotic patient: does size matter?
Hagan MT, Sayuk GS, Lisker-Melman M, Korenblat KM, Kerr TA, Chapman WC, Crippin JS
Dig Dis Sci. 2014 Apr; 59(4)886-91. doi: 10.1007/s10620-014-3038-1.

PMID:
    24504591
    [PubMed - indexed for MEDLINE]
Related citations


Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature.
Blinder MA, Geng B, Lisker-Melman M, Crippin JS, Korenblat K, Chapman W, Shenoy S, Field JJ
Hematol Rep. 2013 Jan 25; 5(1)1-4. doi: 10.4081/hr.2013.e1.

PMID:
    23888237
    [PubMed]
Related citations


Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations.
North CS, Hong BA, Adewuyi SA, Pollio DE, Jain MK, Devereaux R, Quartey NA, Ashitey S, Lee WM, Lisker-Melman M
Gen Hosp Psychiatry. 2013 Mar-Apr; 35(2)122-8. doi: 10.1016/j.genhosppsych.2012.11.002.

PMID:
    23219917
    [PubMed - indexed for MEDLINE]
Related citations


The impact of ethnicity on hepatitis C virus treatment decisions and outcomes.
Lisker-Melman M, Walewski JL
Dig Dis Sci. 2013 Mar; 58(3)621-9. doi: 10.1007/s10620-012-2392-0.

PMID:
    23065087
    [PubMed - indexed for MEDLINE]
Related citations


PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.
Bzowej N, Nelson DR, Terrault NA, Everson GT, Teng LL, Prabhakar A, Charlton MR, PHOENIX Study Group.
Liver Transpl. 2011 May; 17(5)528-38. doi: 10.1002/lt.22271.

PMID:
    21506241
    [PubMed - indexed for MEDLINE]
Related citations


Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis.
Borg BB, Seetharam A, Subramanian V, Basha HI, Lisker-Melman M, Korenblat K, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T
Liver Transpl. 2011 Jul; 17(7)814-23. doi: 10.1002/lt.22303.

PMID:
    21425431
    [PubMed - indexed for MEDLINE]
Related citations


The use of psychoeducation for a patient with hepatitis C and psychiatric illness in preparation for antiviral therapy: a case report and discussion.
Hong BA, North CS, Pollio DE, Abbacchi A, Debold C, Adewuyi SA, Lisker-Melman M
J Clin Psychol Med Settings. 2011 Mar; 18(1)99-107. doi: 10.1007/s10880-011-9227-6.

PMID:
    21336614
    [PubMed - indexed for MEDLINE]
Related citations


Peginterferon α-2a plus ribavirin in Latino and Non-Latino Whites with HCV genotype 1: Histologic outcomes and tolerability from the LATINO Study.
Balart LA, Lisker-Melman M, Hamzeh FM, Kwok A, Lentz E, Rodriguez-Torres M, LATINO study investigators.
Am J Gastroenterol. 2010 Oct; 105(10)2177-85. doi: 10.1038/ajg.2010.157.

PMID:
    20389293
    [PubMed - indexed for MEDLINE]
Related citations


Bone marrow biopsy in patients with hepatitis C virus infection: spectrum of findings and diagnostic utility.
Klco JM, Geng B, Brunt EM, Hassan A, Nguyen TD, Kreisel FH, Lisker-Melman M, Frater JL
Am J Hematol. 2010 Feb; 85(2)106-10. doi: 10.1002/ajh.21600.

PMID:
    20095034
    [PubMed - indexed for MEDLINE]
Related citations


Advanced donor age alone does not affect patient or graft survival after liver transplantation.
Anderson CD, Vachharajani N, Doyle M, Lowell JA, Wellen JR, Shenoy S, Lisker-Melman M, Korenblat K, Crippin J, Chapman WC
J Am Coll Surg. 2008 Dec; 207(6)847-52. doi: 10.1016/j.jamcollsurg.2008.08.009.

PMID:
    19183530
    [PubMed - indexed for MEDLINE]
Related citations


Treatment of chronic hepatitis B: are we ready for combination therapy?
Seetharam A, Lisker-Melman M
Curr Gastroenterol Rep. 2009 Feb; 11(1)22-7.

PMID:
    19166655
    [PubMed - indexed for MEDLINE]
Related citations


Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
Rodriguez-Torres M, Jeffers LJ, Sheikh MY, Rossaro L, Ankoma-Sey V, Hamzeh FM, Martin P, Latino Study Group.
N Engl J Med. 2009 Jan 15; 360(3)257-67. doi: 10.1056/NEJMoa0805062.

PMID:
    19144941
    [PubMed - indexed for MEDLINE]
Related citations

Financial Disclosures

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

This physician reported the following financial interests during calendar year 2017:

Company Name: Abbvie

Royalties: $1 - $9,999

Equity: No

Consulting/Advisory Board: $20,000 - $39,999

Speaker Fees:

Reporting Date: May 01, 2018


Company Name: Gilead

Royalties:

Equity: No

Consulting/Advisory Board:

Speaker Fees: $20,000 - $39,999

Reporting Date: May 01, 2018